Top Markets
#1 EXOD EXOD +56.80%
#2 Cysic Cysic +11.67%
#3 Biconomy Biconomy +9.35%
#4 Arowana Arowana +8.48%
#5 Fake World Assets Fake World Assets +5.60%
#6 Cap Cap +5.11%
#7 Apro Apro +4.87%
#8 Collect on Fanable Collect on Fanable +4.30%
#9 The Black Bull The Black Bull +3.81%
#10 Dual Dual +3.58%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Ra Medical Systems, Inc. Ra Medical Systems, Inc.

Ra Medical Systems, Inc.

RMED
株式のランク #38063
Ra Medical Systems, Inc. operates as a medical technology enterprise... Ra Medical Systems, Inc. operates as a medical technology enterprise specializing in the creation, production, and sale of excimer lasers. These lasers are specifically designed for the management of vascular conditions linked to immune-mediated inflammation. Among its key offerings is the DABRA system, a minimally invasive solution that utilizes an excimer laser and a disposable catheter. This innovative technology enables physicians to perform endovascular treatments, effectively clearing arteriosclerotic blockages in the lower extremities, which are often a result of lower extremity vascular disease, through laser radiation ablation. The company primarily channels its products to the U.S. market through a network of distributors. Founded in 2002, Ra Medical Systems' corporate base is located in Carlsbad, California.
株価
$0.575
最終同期: 2023-09-15
時価総額
$1.24M
変化（1日）
9.00%
変化（1年）
0.00%
国
US
取引 Ra Medical Systems, Inc. (RMED)

カテゴリー

Healthcare
Ra Medical Systems, Inc.（RMED）の収益
Aug 2026 時点の収益 TTM: 0
Ra Medical Systems, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Ra Medical Systems, Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US